RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
C4 Therapeutics Stock

C4 Therapeutics ROCE 2024

C4 Therapeutics ROCE

-0.56

Ticker

CCCC

ISIN

US12529R1077

In 2024, C4 Therapeutics's return on capital employed (ROCE) was -0.56, a 26.13% increase from the -0.45 ROCE in the previous year.

C4 Therapeutics Aktienanalyse

What does C4 Therapeutics do?

The company C4 Therapeutics Inc. was founded in 2015 and is headquartered in Watertown, Massachusetts. The company specializes in the development of drugs that work based on targeted protein degradation. This approach aims to specifically break down proteins in the body that are associated with various diseases. C4 Therapeutics develops special molecules that bind to these proteins and help break them down. The company's business model is based on collaboration with other companies in the pharmaceutical industry, where they develop drug candidates and license them to other companies for further development and marketing. C4 Therapeutics has a specialized strategy to become a leader in the field of targeted protein degradation. They are currently active in various areas, including the development of cancer drugs with a focus on proteins responsible for tumor growth, as well as neurology drugs for diseases like Alzheimer's and Parkinson's. Their important development is the PROTAC platform technology, which allows targeted protein degradation by binding two different molecules to the protein, triggering a cascade of reactions that lead to protein breakdown. Overall, C4 Therapeutics is an innovative and dynamic company specializing in drug development based on targeted protein degradation, with promising potential to treat a range of diseases. Despite being relatively young, the company has already achieved numerous successes and is expected to play an important role in the pharmaceutical industry in the future. C4 Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling C4 Therapeutics's Return on Capital Employed (ROCE)

C4 Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing C4 Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

C4 Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in C4 Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about C4 Therapeutics stock

What is the ROCE (Return on Capital Employed) of C4 Therapeutics this year?

The ROCE of C4 Therapeutics is -0.56 undefined this year.

How has the ROCE (Return on Capital Employed) of C4 Therapeutics developed compared to the previous year?

The ROCE of C4 Therapeutics has increased by 26.13% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of C4 Therapeutics?

A high Return on Capital Employed (ROCE) indicates that C4 Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of C4 Therapeutics?

A low ROCE (Return on Capital Employed) can indicate that C4 Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from C4 Therapeutics impact the company?

An increase in the ROCE of C4 Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of C4 Therapeutics affect the company?

A decrease in ROCE of C4 Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of C4 Therapeutics?

Some factors that can affect C4 Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of C4 Therapeutics so important for investors?

The ROCE of C4 Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can C4 Therapeutics take to improve the ROCE?

To improve the ROCE, C4 Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does C4 Therapeutics pay?

Over the past 12 months, C4 Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, C4 Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of C4 Therapeutics?

The current dividend yield of C4 Therapeutics is .

When does C4 Therapeutics pay dividends?

C4 Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of C4 Therapeutics?

C4 Therapeutics paid dividends every year for the past 0 years.

What is the dividend of C4 Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is C4 Therapeutics located?

C4 Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von C4 Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of C4 Therapeutics from 8/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/24/2024.

When did C4 Therapeutics pay the last dividend?

The last dividend was paid out on 8/24/2024.

What was the dividend of C4 Therapeutics in the year 2023?

In the year 2023, C4 Therapeutics distributed 0 USD as dividends.

In which currency does C4 Therapeutics pay out the dividend?

The dividends of C4 Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von C4 Therapeutics

Our stock analysis for C4 Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of C4 Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.